| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |